{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "Y",
          "alt": "C",
          "position": 1699
        },
        "variant_string_id": "LRRK2 Y1699C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the leucine-rich repeat kinase 2(LRRK2) gene are the most prevalent known cause of autosomal dominant Parkinson's disease(PD).",
          "judgment": "Yes",
          "reasoning": "文章明确指出了LRRK2基因突变与常染色体显性帕金森病之间的关系。"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "We observed a decrease in GTPase activity for LRRK2 Y1699C comparable to the decrease observed for the R1441C pathogenic mutant and the T1348N dysfunctional mutant.",
          "judgment": "Yes",
          "reasoning": "使用的酶偶联稳态GTPase测定法有效反映了LRRK2 GTPase活性的变化，符合疾病机制。",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Step 3a: Basic Controls and Replicates: GTPase activity was confirmed in two independent experiments.\n\nStep 3c: Variant Controls: The same pattern of lower GTPase activity was observed for the R1441C mutant.",
          "judgment": "Yes",
          "reasoning": "Step 3a: Basic Controls and Replicates: 实验中使用了多个重复实验，并且包含了野生型和已知功能丧失突变体作为对照。\n\nStep 3c: Variant Controls: 使用了已知的致病性突变体（如R1441C）作为对照。"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Step 4b: No OddsPath Calculation: We observed a decrease in GTPase activity for LRRK2 Y1699C comparable to the decrease observed for the R1441C pathogenic mutant and the T1348N dysfunctional mutant.",
          "judgment": "Partial",
          "reasoning": "Step 4b: No OddsPath Calculation: 文中提到的多个对照变体（包括R1441C、T1348N等），总数超过11个。"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "LRRK2 Y1699C突变导致GTPase活性显著降低，实验设计合理，包括了野生型和已知致病性突变体作为对照，且重复实验验证了结果的可靠性，因此该变体的功能证据支持其致病性。"
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "C",
          "position": 1441
        },
        "variant_string_id": "LRRK2 R1441C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the leucine-rich repeat kinase 2(LRRK2) gene are the most prevalent known cause of autosomal dominant Parkinson's disease(PD).",
          "judgment": "Yes",
          "reasoning": "文章明确指出了LRRK2基因突变与常染色体显性帕金森病之间的关系。"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "We observed a decrease in GTPase activity for LRRK2 R1441C.",
          "judgment": "Yes",
          "reasoning": "使用的酶偶联稳态GTPase测定法有效反映了LRRK2 GTPase活性的变化，符合疾病机制。",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Step 3a: Basic Controls and Replicates: GTPase activity was confirmed in two independent experiments.\n\nStep 3c: Variant Controls: The same pattern of lower GTPase activity was observed for the R1441C mutant.",
          "judgment": "Yes",
          "reasoning": "Step 3a: Basic Controls and Replicates: 实验中使用了多个重复实验，并且包含了野生型和已知功能丧失突变体作为对照。\n\nStep 3c: Variant Controls: 使用了已知的致病性突变体（如R1441C）作为对照。"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Step 4b: No OddsPath Calculation: We observed a decrease in GTPase activity for LRRK2 R1441C.",
          "judgment": "Partial",
          "reasoning": "Step 4b: No OddsPath Calculation: 文中提到的多个对照变体（包括R1441C、T1348N等），总数超过11个。"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "LRRK2 R1441C突变导致GTPase活性显著降低，实验设计合理，包括了野生型和已知致病性突变体作为对照，且重复实验验证了结果的可靠性，因此该变体的功能证据支持其致病性。"
    }
  ]
}